CATALOGO DEI PRODOTTI DELLA RICERCA

VATTEMI, Gaetano Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.226
EU - Europa 4.817
AS - Asia 3.697
SA - Sud America 557
AF - Africa 118
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 15.426
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.112
RU - Federazione Russa 1.868
SG - Singapore 1.467
CN - Cina 1.079
GB - Regno Unito 906
BR - Brasile 469
IT - Italia 400
DE - Germania 346
VN - Vietnam 345
HK - Hong Kong 303
FR - Francia 268
SE - Svezia 262
FI - Finlandia 250
IE - Irlanda 204
KR - Corea 128
UA - Ucraina 88
CA - Canada 67
BD - Bangladesh 63
IN - India 61
TR - Turchia 59
NL - Olanda 48
JP - Giappone 36
AR - Argentina 35
ID - Indonesia 35
MX - Messico 33
PL - Polonia 31
BE - Belgio 29
NG - Nigeria 28
ZA - Sudafrica 27
ES - Italia 24
IQ - Iraq 22
PK - Pakistan 21
AT - Austria 19
RO - Romania 14
CH - Svizzera 11
EC - Ecuador 11
CL - Cile 10
KE - Kenya 10
UZ - Uzbekistan 10
BJ - Benin 9
MA - Marocco 9
LT - Lituania 8
MY - Malesia 8
TG - Togo 8
IL - Israele 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
EG - Egitto 6
PY - Paraguay 6
UY - Uruguay 6
AU - Australia 5
DO - Repubblica Dominicana 5
GR - Grecia 5
JO - Giordania 5
NP - Nepal 5
PE - Perù 5
PH - Filippine 5
SA - Arabia Saudita 5
AL - Albania 4
AZ - Azerbaigian 4
BG - Bulgaria 4
KZ - Kazakistan 4
AM - Armenia 3
CG - Congo 3
DZ - Algeria 3
LB - Libano 3
NO - Norvegia 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HR - Croazia 2
KG - Kirghizistan 2
LV - Lettonia 2
MT - Malta 2
MU - Mauritius 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
TN - Tunisia 2
TW - Taiwan 2
AO - Angola 1
AQ - Antartide 1
BS - Bahamas 1
CD - Congo 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GN - Guinea 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
Totale 15.411
Salva come PNG Salva come JPEG
Città #
Dallas 964
Singapore 775
Southend 740
Moscow 683
Ashburn 631
San Jose 582
Chandler 552
Jacksonville 496
Woodbridge 379
Hong Kong 299
Verona 228
Beijing 216
Dublin 203
Ann Arbor 202
Houston 182
The Dalles 156
Munich 141
New York 138
Council Bluffs 121
Los Angeles 114
Ho Chi Minh City 111
Wilmington 83
Helsinki 82
Lawrence 82
Princeton 82
Hanoi 78
Jinan 78
Shenyang 66
Nanjing 61
São Paulo 51
Columbus 41
Tianjin 39
Santa Clara 38
Hebei 36
Buffalo 35
Orem 35
London 31
Redondo Beach 31
Tokyo 30
Brussels 28
Haikou 27
Seattle 27
Turku 27
Warsaw 27
Amsterdam 26
Seoul 26
Sindelfingen 26
Abuja 25
Boardman 25
Milan 24
Denver 23
Montreal 23
Toronto 23
Chennai 22
Hangzhou 22
Jakarta 22
Johannesburg 22
Chicago 21
Nanchang 21
Ningbo 21
Changsha 20
Guangzhou 20
Taizhou 20
Haiphong 19
Poplar 19
Taiyuan 19
Dearborn 18
Frankfurt am Main 18
Jiaxing 18
Nuremberg 18
Zhengzhou 18
Phoenix 17
Lappeenranta 15
San Francisco 15
Atlanta 14
Da Nang 14
Rio de Janeiro 14
Fuzhou 13
Stockholm 13
Washington 13
Bologna 12
Brooklyn 12
Norwalk 12
Kent 11
Manchester 11
Redwood City 11
Mexico City 10
Nairobi 10
Redmond 10
Vienna 10
Belo Horizonte 9
Boston 9
Cotonou 9
Falkenstein 9
Lancaster 9
Tashkent 9
Zurich 9
Ankara 8
Lomé 8
Mumbai 8
Totale 9.931
Salva come PNG Salva come JPEG
Nome #
A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates. 324
Abnormal expression of RNA polymerase II associated proteins in muscle of patients with myofibrillar myopathies. 271
Acute inflammatory demyelinating polyneuropathy as a manifestation of chronic lymphoproliferative disorder of NK cells. 253
Overexpression of TNF-α in mitochondrial diseases caused by mutations in mtDNA: evidence for signaling through its receptors on mitochondria. 249
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 241
Differential regulation of TNF receptors in maternal leukocytes is associated with severe preterm preeclampsia. 232
Bortezomib-induced muscle toxicity in multiple myeloma 232
Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement. 224
Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases 220
Autophagy, inflammation and innate immunity in inflammatory myopathies. 218
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 218
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction 216
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma. 210
BACE1 and BACE2 in pathologic and normal human muscle 208
Endothelial dysfunction and increased oxidative stress in mitochondrial diseases. 199
A novel emerin gene mutation in Emery Dreifuss muscular dystrophy patient with spontaneous chordae tendinae rupture 199
A novel de novo GFAP variant causes a juvenile-onset Alexander disease with bilateral vocal cord paralysis 197
Pisa syndrome in Parkinson's disease: an electrophysiological and imaging study. 197
Chronic graft-versus-host-disease-related polymyositis: a 17-months-old child with a rare and late complication of haematopoietic stem cell transplantation 193
Adult-onset muscular dystrophy in a cat associated with a presumptive alteration in trafficking of caveolin-3. 192
Evidence for caspase-dependent programmed cell death along with repair processes in affected skeletal muscle fibres in patients with mitochondrial disorders 192
McArdle disease and sporadic inclusion-body myositis. 189
A new mutation in the mitochondrial tRNA(Ala) gene in a patient with ophthalmoplegia and dysphagia 188
Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids 186
Brody Disease: insights into biochemical features of SERCA1 and identification of a novel mutation. 186
Selective pseudohypertrophy of vastus medialis muscles associated with calpain 3 deficiency. 186
Amyloid myopathy: an intriguing diagnosis 186
Acute sarcomeric M-Line Disease associated with ATP synthase subunit α autoantibodies in ankylosing spondylitis 184
A novel in-frame deletion in MYOT causes an early adult onset distal myopathy 183
Autoantibody testing in patients with myositis: clinical accuracy of a multi parametric line immunoassay 181
Brody syndrome: A clinically heterogeneous entity distinct from Brody disease: A review of literature and a cross-sectional clinical study in 17 patients. 180
Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis. 179
Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy. 179
Calpain 3 deficiency presenting as fiber type disproportion. 175
Endothelial dysfunction in mitochondrial diseases: biological and biochemical evidence of increased oxidative stress and peroxinitrite generation 174
Characterization of sarcoplasmic reticulum Ca(2+) ATPase pumps in muscle of patients with myotonic dystrophy and with hypothyroid myopathy 172
Non-hematologic toxicity of bortezomib in multiple myeloma: the neuromuscular and cardiovascular adverse effects 172
Immunoblot as a potential diagnostic tool for myofibrillar myopathies 170
Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta 170
Polymyositis in solid organ transplant recipients receiving tacrolimus. 168
Muscular dystrophy with reduced beta-sarcoglycan in a cat. 167
T-cell anti-apoptotic mechanisms in inflammatory myopathies 166
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy 165
Chronic ophthalmoparesis in limb girdle muscular dystrophy 1C. 164
Cutis verticis gyrata, mental retardation and Lennox-Gastaut syndrome: a case report 163
SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers. 163
Programmed cell death occurs in muscle fibers with mitochondrial dysfunction 161
The role of muscle biopsy in investigating isolated muscle pain 161
Evidence of ER stress and UPR activation in patients with Brody disease and Brody syndrome 160
Human skeletal muscle as a target organ of trichloroethylene toxicity. 158
Clinical, morphological and genetic characterization of Brody disease: an international study of 40 patients 157
Multiple acyl-COA dehydrogenase deficiency in elderly carriers 155
Expanding the clinical and genetic spectrum of pathogenic variants in STIM1 155
Transcription factors c-Jun/activator protein-1 and nuclear factor-kappa B in oxidative stress response in mithocondrial diseases 152
Whole-exome sequencing in patients with protein aggregate myopathies reveals causative mutations associated with novel atypical phenotypes 151
Transthyretin Val122Ile, accumulated Aβ, and inclusion-body myositis aspects in cultured muscle 150
Expression of Protein Kinase C isoforms and interleukin-1beta in myofibrillar myopathy 149
SERCA1 and calsequestrin storage myopathy: a new surplus protein myopathy. 148
Sarcoidosis and inclusion body myositis. 147
Pearls & Oy-sters: An unusual case of varicella-zoster virus cerebellitis and vasculopathy. 147
Acetylcholine receptor-antibody-positive myasthenia gravis presenting with early atrophy and nonfluctuating weakness of proximal limb muscles 146
Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles 144
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse. 139
Upper camptocormia in Parkinson's disease: Neurophysiological and imaging findings of both central and peripheral pathophysiological mechanisms 138
Protein expression of canine and feline muscular dystrophies 138
Persistent dystrophin protein restoration 90 days after a course of intraperitoneally administered naked 2'OMePS AON and ZM2 NP-AON complexes in mdx mice. 137
Relapsing-remitting painful masses of the skeletal muscle 137
Reversible upper limb muscle weakness with selective loss of thick filaments 137
Neuropathology of mitochondrial diseases 136
Human mutated MYOT and CRYAB genes cause a myopathic phenotype in Zebrafish 135
Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. 131
Expression of late myogenic differentiation markers in sarcoplasmic masses of patients with myotonic dystrophy 127
Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency: delayed hypersensitivity reaction and efficacy of low-dose intermittent supplementation 122
Identification and characterization of three novel mutations in the CASQ1 gene in four patients with tubular aggregate myopathy 122
Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis 120
Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers 118
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts 117
Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis 117
Neurogenic disease with high CK: think muscle 116
Uptake and intracellular distribution of different types of nanoparticles in primary human myoblasts and myotubes 113
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 113
Eyelid ptosis from sympathetic nerve dysfunction mistaken as myopathy: a simple test to identify this condition 112
Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes. 112
Ryanodine receptor 1 (RYR1) mutations in two patients with tubular aggregate myopathy 112
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfa 111
Dermatomyositis and retroperitoneal germ cell cancer 111
Transcriptional behavior of DMD gene duplications in DMD/BMD males. 109
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. 108
Physical training promotes remodeling of the skeletal muscle extracellular matrix: An ultrastructural study in a murine model of Down syndrome 94
Novel mitochondrial tRNA(Leu(CUN)) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype 94
Sporadic inclusion body myositis at the crossroads between muscle degeneration, inflammation, and aging 84
Premature skeletal muscle aging in VPS13A deficiency relates to impaired autophagy 84
Physical activity practiced at a young age is associated with a less severe subsequent clinical presentation in facioscapulohumeral muscular dystrophy 74
Clinical, Histopathologic, and Genetic Features of Patients With Myofibrillary and Distal Myopathies: Experience From the Italian Network 74
Toll-like receptors and IL-7 as potential biomarkers for immune-mediated necrotizing myopathies 71
Evaluation of aggrephagy markers in myofibrillar myopathies 67
The FSHD jigsaw: are we placing the tiles in the right position? 66
Nucleolar FRG2 lncRNAs inhibit rRNA transcription and cytoplasmic translation, linking FSHD to dysregulation of muscle-specific protein synthesis 56
Case Report: Simultaneous presentation of end-stage heart failure with cardiogenic shock requiring emergency transplantation in monozygotic twins with myofibrillar myopathy: a previously unknown genetic disease? 40
Assessment of IBM-FRS total score and specific functional domains in a large cohort of inclusion body myositis patients 30
Totale 15.544
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.673
article - articoli 48.622
book - libri 0
conference - conferenze 1.051
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.346
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022715 86 275 2 47 18 13 8 38 17 12 48 151
2022/20231.474 113 166 143 233 154 329 14 89 177 11 23 22
2023/2024724 29 74 54 73 77 134 27 70 10 44 83 49
2024/20252.324 104 108 80 340 129 112 197 146 366 133 183 426
2025/20267.176 418 692 587 1.103 1.714 427 661 321 570 384 109 190
Totale 15.571